Equity Research
William Blair research analyst Margaret Kaczor was quoted by MedTech Dive in its coverage of how biopharma companies are investing in and developing new technology solutions to assist those living with diabetes.
“I think they think it will be big. I think that’s yet to be proven,” Kaczor shared in regards to one company’s investment in its innovations in diabetes technology solutions.
Stay up-to-date with the latest William Blair news and insights
Jed Dorsheimer welcomes Doomberg for an in-depth discussion on the complexities of renewable energy integration and its impact on grid efficiency, exploring the challenges posed by the variability of renewables, the resurgence of nuclear power, and the critical role of natural gas in bridging the energy transition.
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, is thrilled to announce its performance in the annual Coalition Greenwich Voice of the Client – 2024 North American Equity Investors Study.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
